Several big-name drugmakers are weighing in on the opportunity in the weight-loss drugs market.
Tag Archive for: Eccogene
AstraZeneca raised its annual earnings forecast on Thursday, helped by strong demand for its cancer drugs, and moved to boost its pipeline in the booming anti-obesity market with a deal costing up to $2 billion.